Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

Audio By Carbonatix

MADISON, Wis.--(BUSINESS WIRE)--Feb 3, 2025--

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2024 financial results after the close of the U.S. financial markets on February 19, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

 A replay of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250203349082/en/

CONTACT: Erik Holznecht

Exact Sciences Corp.

[email protected]

608-800-6605

KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN

INDUSTRY KEYWORD: ONCOLOGY MEDICAL SUPPLIES MEDICAL DEVICES HEALTH GENERAL HEALTH BIOTECHNOLOGY

SOURCE: Exact Sciences Corp.

Copyright Business Wire 2025.

PUB: 02/03/2025 06:00 AM/DISC: 02/03/2025 06:01 AM

http://www.businesswire.com/news/home/20250203349082/en